Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

629 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regional advisory board position statement on optimal pneumococcal vaccination in adults. Update to 2011 consensus on adult pneumococcal disease: update on optimal pneumococcal vaccination in adults.
Ludwig E, Unal S, Bogdan M, Chlíbek R, Ivanov Y, Kozlov R, Lode H, Mészner Z, Prymula R, Rahav G, Skoczyńska A, Solovic I, Sayiner A. Ludwig E, et al. Among authors: lode h. Cent Eur J Public Health. 2013 Dec;21(4):233-6. doi: 10.21101/cejph.a3959. Cent Eur J Public Health. 2013. PMID: 24592732 Free article.
Pneumococcal vaccination.
de Roux A, Lode H. de Roux A, et al. Among authors: lode h. Eur Respir J. 2005 Dec;26(6):982-3. doi: 10.1183/09031936.05.00119705. Eur Respir J. 2005. PMID: 16319323 Free article. No abstract available.
Treatment of pneumonia in elderly patients.
Schmidt-Ioanas M, Lode H. Schmidt-Ioanas M, et al. Among authors: lode h. Expert Opin Pharmacother. 2006 Apr;7(5):499-507. doi: 10.1517/14656566.7.5.499. Expert Opin Pharmacother. 2006. PMID: 16553566 Review.
Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
Lode H, File TM Jr, Mandell L, Ball P, Pypstra R, Thomas M; 185 Gemifloxacin Study Group. Lode H, et al. Clin Ther. 2002 Nov;24(11):1915-36. doi: 10.1016/s0149-2918(02)80088-1. Clin Ther. 2002. PMID: 12501883 Clinical Trial.
629 results